Andere Sprachen Harbin Pharmaceutical Group Co., Ltd.

Aktien

A0M3QV

CNE0000009T3

600664

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 14.05.2024			% 5 Tage	% 1. Jan.
3,16 ^CNY	+0,96 %		+0,32 %	-5,67 %

25.04.	Harbin Pharmaceutical Group Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
11.04.	Harbin Pharma modernisiert die Produktionsbasis seiner Tochtergesellschaft für 50 Millionen Yuan	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25.04.
Harbin Pharma to Upgrade Subsidiary's Production Base for 50 Million Yuan	11.04.
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	10.04.
Roxatidine Hydrochloride for Injection of Harbin Pharma's Subsidiary Passes Drug Regulator's Evaluation	08.02.
Harbin Pharmaceutical Group's Cefotiam Hydrochloride Selected for China's Centralized Procurement Bid	08.11.
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26.10.23
Harbin Pharmaceutical Group Co., Ltd.(XSSC:600664) added to S&P Global BMI Index	18.09.23
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24.08.23
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27.04.23
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	12.01.23
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26.10.22
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25.08.22
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27.04.22
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	08.04.22
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	25.10.21
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	15.08.21
Jian´anxi Food Technology Co., Ltd announced that it expects to receive $20 million in funding from Harbin Pharmaceutical Group Co., Ltd.	08.06.21
Ecmoho Limited and Harbin Pharmaceutical Group Announce Joint Launch of New Iron Supplement Product	17.05.21
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	28.04.21
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	02.04.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Harbin Pharmaceutical Group Co., Ltd.

Aktien

A0M3QV

CNE0000009T3

600664

Andere Sprachen

Filter